TARTAN LLC
SAN DIEGO, CA · Founded 2021 · CIK 0001866378 · Biotech · Private
RNA editing therapy for SCN1A mutations in Dravet syndrome using cell-type-specific targeting
tartan.com →- Grants
- $256K
- 1 award
- Sector median: 1
- Raised
- $130K
- 1 Form D · Aug 2021
- 62 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20212022
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | National Science Foundation · Phase I · STTR Phase I: Harnessing the power of introns for safe and effective therapeutics and genomic screening | $255,730 | |
| Private capital raised | Form D · SEC | $130,000 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2650 | SIDERO BIOSCIENCE, LLC | — | $145K |
| 2651 | ORION THERAPEUTICS INC. | — | $145K |
| 2652 | Finch Therapeutics, Inc. | — | $4.5M |
| 2653 | TARTAN LLC | — | $130K |
| 2654 | NEUIMMUNE, INC. | — | $125K |
| 2655 | RESTORE THERAPEUTICS LLC | — | — |
| 2656 | nVector, Inc. | — | $125K |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Christopher DoyleDirector · Executive Officer · Promoter
- Sage RatermanDirector · Executive Officer · Promoter
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.